U.S. patent number 3,692,897 [Application Number 04/873,795] was granted by the patent office on 1972-09-19 for immunological method and composition for controlling the sex of mammalian offspring.
This patent grant is currently assigned to Bio-Controls, Inc.. Invention is credited to Bhairab Chandra Bhattacharya, Gustaaf J. VAN DEN Bovenkamp.
United States Patent |
3,692,897 |
Bhattacharya , et
al. |
September 19, 1972 |
IMMUNOLOGICAL METHOD AND COMPOSITION FOR CONTROLLING THE SEX OF
MAMMALIAN OFFSPRING
Abstract
An immunological method for controlling the sex of mammalian
offspring, making use of spermatozoa which has been previously
separated into fractions having the desired sex characteristics an
antigens. A substantially pure sperm fraction containing the sex
chromosomes of a single type (i.e., X chromosomes or Y chromosomes)
is introduced into the body of a mammal in sufficient quantity to
produce antibodies in the blood stream. A blood sample is then
taken from the mammal, the blood coagulated and the blood serum
containing the antibodies isolated. Fresh mammalian sperm is
inoculated with the blood serum to inactivate and destroy sperm
reactive with the antibodies in the blood serum and the treated
sperm used to artificially inseminate the female, thereby inducing
conception and offspring of desired sex as determined by the
remaining unreacted sperm. In one application of the invention,
antibodies reactive with either the X or Y chromosomes may be added
to a dose of semen to cause death to sperm containing that type of
chromosome before insemination. Alternatively, the antibodies may
be introduced into the female either prior or subsequent to
copulation (e.g., in a vaginal jelly or as a vaccine) to provide
the possibility of sex selection at conception or possible
embryonic death to a fetus of undesired sex.
Inventors: |
Bhattacharya; Bhairab Chandra
(Omaha, NB), VAN DEN Bovenkamp; Gustaaf J. (Mill Valley,
CA) |
Assignee: |
Bio-Controls, Inc.
(N/A)
|
Family
ID: |
25362331 |
Appl.
No.: |
04/873,795 |
Filed: |
November 4, 1969 |
Current U.S.
Class: |
424/172.1;
424/811 |
Current CPC
Class: |
C07K
16/18 (20130101); G01N 33/531 (20130101); A61K
38/00 (20130101); Y10S 424/811 (20130101) |
Current International
Class: |
G01N
33/531 (20060101); C07K 16/18 (20060101); A61K
38/00 (20060101); A61k 027/00 () |
Field of
Search: |
;424/85 |
Primary Examiner: Huff; Richard L.
Claims
We claim:
1. In a method for isolating antibodies capable of entering into
antibody reactions with sperm containing sex chromosomes of only
one type, said antibodies having no appreciable effect on sperm
containing sex chromosomes of the opposite type, the steps of
introducing a separated substantially pure sperm fraction
containing sex chromosomes of a single sex type into the body of a
mammal, said sperm fraction containing sperm in sufficient quantity
to induce production of antibodies in the blood of said mammal,
removing a portion of the blood of said mammal, coagulating the
blood so removed and separating therefrom the blood serum
containing antibodies reactive only to sperm of the sex type
present in said sperm fraction.
2. A method as in claim 1 wherein the said sperm fraction is
introduced into the body of the mammal in successive steps, each
step involving the introduction of a portion of the separated sperm
fraction.
3. A method as in claim 1 wherein the blood serum containing
antibodies is inactivated by heating at a temperature of the order
of 56.degree. C.
Description
CROSS REFERENCE TO RELATED APPLICATION
Reference is made to the co-pending application of Bhairab Chandra
Bhattacharya, Ser. No. 443,473, filed Mar. 29, 1965, wherein a
method and means for separating sperm into fractions containing
substantially all X chromosomes, or all Y chromosomes, is
disclosed.
BACKGROUND OF THE INVENTION
As pointed out in the aforementioned co-pending application, the
sex of offspring is controlled by the chromosomes of the particular
spermatozoon or sperm cell which fertilizes the egg. More
specifically, some spermatozoa (hereinafter called "sperm") are
genetypically known to contain X chromosomes which carry female
producing genes, while others contain Y chromosomes which carry
male producing genes. As further disclosed therein, the sperm
containing X chromosomes (hereinafter called X-sperm) are somewhat
more dense than the sperm containing the Y chromosomes (hereinafter
called Y-sperm). This difference in density makes possible the
separation of sperm in the ejaculation of a mammalian male to
obtain substantially pure sperm fractions containing either X-sperm
or Y-sperm. The disclosed separation technique is suitable for use
with all mammals, including human beings and other primates,
cattle, swine (i.e., hogs and pigs), sheep, rabbits, cats, goats,
horses, donkeys and buffalo. In general the method of separation is
to apply a buoyant force to the sperm to cause the more buoyant
sperm to attain a different level in a separation medium than the
less buoyant sperm, the buoyant force being either positive or
negative. In the technique specifically described, the sperm is
separated by sedimentation in a system wherein gravity acts as a
negative buoyant force.
In the method disclosed in the above identified co-pending
application, the sex of offspring is controlled by artificially
inseminating the female with a separated sperm fraction, containing
either X-sperm or Y-sperm, to thereby obtain offspring of the
desired sex.
SUMMARY OF THE INVENTION AND OBJECTS
This invention relates generally to an immunological method for
controlling sex of mammalian offspring, and to compositions useful
in providing offspring of one sex. More particularly, the invention
relates to an immunological method for isolating antibody
compositions reactive with sperm containing sex chromosomes of only
one type, and to the use of such antibody compositions to permit
conception by sperm containing chromosomes of the opposite
type.
The present invention is predicated on our discovery that the two
sperm genotypes of mammals (X and Y) possess different antigenic
properties, and that this difference in antigenic properties can be
employed to create antibodies which are physico-chemically specific
in their reactions with respect to either the X-sperm or Y-sperm
present in mammalian sperm. The term "antibody" is used herein to
identify the substance or substances produced within the body of a
mammal in response to the introduction of a substantially pure
sperm fraction containing either X-sperm or Y-sperm. Thus, in the
practice of the invention, a substantially pure sperm fraction
containing sex chromosomes of one type can be injected under the
skin or in the abdomen or even in a vein of a mammal, according to
normal procedures, and the mammal will produce in its blood
chemical substances, viz., antibodies, which will act to inactivate
and destroy sperm of the same type as injected. Since the
antibodies thus produced are reactive with sperm containing sex
chromosomes of only one type, they have no appreciable effect on
sperm containing sex chromosomes of the opposite type. This sex
selectivity of the antibodies makes possible a choice or selection
of the ultimate sex of offspring through use of various techniques,
for example, by inoculation of fresh sperm to cause death of one of
the two types of sperm present before insemination, or by
introduction of the antibody into the vaginal cavity before or
after copulation by various known techniques. The present invention
accordingly enables parents, breeders of animals, farmers, and
others engaged in the field of animal husbandry to deliberately
control or select the sex of offspring to obtain a child, calf,
colt, or other animal of a particular desired sex.
In general, it is an object of the present invention to provide a
truly successful, immunological method for controlling the sex of
mammalian offspring.
Another object of the present invention is to provide a method for
isolating antibodies in a form capable of entering into antibody
reactions with sperm containing sex chromosomes of only one
type.
Another object of the present invention is to provide a method for
isolating antibodies capable of being used in procedures for
artificial insemination of the female, to obtain offspring of the
desired sex.
A further object of the invention is to provide novel compositions
containing antibodies reactive to inactivate and destroy either
X-sperm or Y-sperm, thereby enabling use of such compositions to
cause death of one type of sperm in a mammalian ejaculate prior or
subsequent to insemination.
A still further object of the invention is to provide novel
compositions of the above character which can be positively tested
prior to use, to ensure their utility as anti-serums with respect
to sperm of particular sex characteristics.
Additional objects and advantages of the invention will appear from
the following description in which the preferred embodiments have
been set forth in detail in conjunction with the accompanying
drawing.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a flow sheet illustrating the method of the present
invention.
DESCRIPTION OF PREFERRED EMBODIMENT
As illustrated in FIG. 1, a substantially pure sperm fraction,
which may be either substantially pure X-sperm or Y-sperm, is
isolated by techniques known or available in the art. For example,
substantially pure X or Y-sperm fractions can be isolated in
accordance with the procedure of the aforementioned co-pending
application, Ser. No. 443,473. While sedimentation is specifically
described therein as a procedure for separating a pure X or Y-sperm
fraction, other procedures may also be used, for example, employing
forces greater than gravity in a centrifuge or forces to achieve
positive buoyancy as well as sedimentation in columns containing
media of carefully controlled density. In general, the sperm
fraction so isolated is maintained and preserved within a nutrient
medium such as fresh mammalian milk or other body fluids and
nutrient liquids, as herein disclosed.
Referring to the flow sheet of FIG. 1, the separated, substantially
pure fraction of either X or Y-sperm is introduced into the body of
a mammal, in step 11, as an antigen, the purpose being to induce
antibody production in the blood of such mammal. In accordance with
known procedures, the antigen sperm fraction can be injected in
successive doses to induce antigenic stimulation, leading to the
highest possible levels of antibody formation. In due course a
blood sample is removed from the mammal, in step 12, and the blood
allowed to coagulate, as in step 13. The coagulation of the blood
(a phenomenon related to clotting of the plasma) causes the
non-coaguable blood sperm to separate from the blood cells and
coagulated plasma, as represented in step 14. The blood sperm
separated in step 14 is of primary importance to the method of the
present invention, for it contains the antibodies developed as a
result of introduction of the sperm fraction as an antigen. While
the precise mechanism by which the antibodies are formed in the
blood stream of the mammal is not known or fully understood, it is
evident that the antibodies are finally present in the blood serum
as separated in step 14. In a preferred practice of the invention,
the blood serum separated in step 14 is inactivated by heating in
step 15, viz, at a temperature of 56.degree.C. for a period of
about 1/2 hour. The blood serum containing antibodies of desired
type is now in form suitable for carrying out antibody reactions in
accordance with the present invention. If desired, the blood serum
in this form may be separated and held as an intermediate product,
represented at 16.
As further illustrated in the flow sheet of FIG. 1, fresh sperm is
collected from the male, in step 17, and in such form contains
equal amounts of X-sperm and Y-sperm. The fresh sperm can now be
mixed with the blood serum or antiserum, in step 18, to initiate
the antibody reactions previously described. Assuming the use of
X-sperm as an antigen in step 11, the antibody reactions will be
specific to the X-sperm present in the freshly collected sperm and
will act to cause death of the X-sperm. Alternatively, where
Y-sperm is used as the antigen in step 11, the antibody reactions
will cause death of the Y-sperm present in the freshly collected
material. The resulting sperm, containing approximately equal
amounts of inactive X-sperm (or Y-sperm) and viable Y-sperm (or
X-sperm), as the case may be, is used in step 19 to artificially
inseminate a female of the species from which the sperm was taken.
It will be understood that prior to insemination, the sperm
collected in step 17 may be mixed with an appropriate nutrient
medium and gradually cooled, or otherwise preserved, in accordance
with the procedures generally described in the aforementioned
co-pending application, Ser. No. 443,473.
As noted previously, the immunological method of the present
invention is suitable for use with all mammals. Of particular
interest are human beings and other primates, cattle, swine (i.e.,
hogs and pigs), sheep, rabbits, cats, goats, horses, donkeys and
buffalo. In general, the antigenecity of a mammalian cell is under
the influence or regulated by the cell nucleus. In the case of
mammalian sperm, the X-sperm and Y-sperm differ in chromosomal
structure and very possibly in other properties. For example, in
microscopes, the X chromosomes appear larger in size than the Y
chromosomes. The probability of a difference in antigenic
properties between X-sperms and Y-sperms is believed to be related
to this difference in chromosomal structure and to contribute in a
direct way to the capacity of a mammal to create different
antibodies when injected with either X or Y-sperm. Accordingly, a
sperm fraction effective to carry out the present invention should
contain a sufficient proportion of either X or Y-sperm, according
to the selection, to ensure some success in achieving a desired
proportion of antibodies. Generally this proportion should be at
least 70percent. For practical or commercial purposes, however, at
least 80 to 90 percent of the sperm in the antigen sperm fraction
should possess a known sex characteristic to ensure that the chance
of success in producing antibodies of the desired type is
statistically tolerable. Of course, a sperm fraction containing 100
percent sperm of known type is the most desirable since there then
is no chance of error. Also, a high proportion of sperm of known
sex characteristics in the antigen sperm fraction makes possible a
simple test of the anti-serum capacity of the blood serum (obtained
in step 14), as hereinafter described.
The disclosure herein makes reference to an "immunological" method
for controlling the sex of mammalian offspring. In a strict
technical sense, the analogy to techniques for acquiring or
imparting immunity is somewhat inaccurate, since sperm are not
properly classified as pathogenic or infectious organisms. On the
other hand, the present invention makes use of available techniques
for preparing immune serums, or anti-serums. To illustrate,
procedures for artificially generating passive immunity in mammals
most generally involve the introduction of the undesired
microorganism into the body of an experimental animal, commonly the
rabbit, horse, goat or the sheep, to thereby induce production of
antibodies against the injected microorganism. Thus, in
conventional immunization technology, active immunity is effected
by stimulating the production of antibodies through use of the
appropriate infectious microorganism as an antigen. In the present
case however, the antigen is constituted by living or dead
microorganisms in the form of either X-sperm or Y-sperm. Although
the techniques employed in the present invention may be equated in
terms to those used in conventional procedures for providing
passive immunity, (e.g., an anti-serum may be obtained from a
mammal which has been previously hyperimmunized to X or Y-sperm
through production of antibodies) the "immunity" actually provided
is not to infection or disease in the normal sense, but rather to
birth of offspring of undesired sex. Moreover, while such immunity
may properly, be classified as immediate or of short-term, it is
absolute in the sense that conception is prevented by destruction
of the unwanted type of sperm. Consideration of the present
invention should therefore take into account the foregoing
distinctions as well as analogies.
As a generalized example, illustrating the practice of the
invention, anti-serums containing antibodies against either X-sperm
or Y-sperm can be prepared as follows:
Fresh bull sperm is subjected to processing by sedimentation or
centrifugation, as described in the co-pending application, Ser.
No. 443,473, to obtain a substantially pure sperm fraction (e.g.,
20,000,000 sperm of which approximately 80 percent are X-sperm).
The bull sperm is washed out of the separation medium by
centrifuging in a tube at 2,000 r.p.m. for 10 minutes, the
centrifugal force thus developed causing the X-sperms to move to
the bottom of the centrifuge tube After decanting the supernatant,
the sperm are suspended in saline (0.9 percent NaCl in distilled
H.sub.2 O) and then washed two more times by an identical
procedure, viz, involving centrifuging at 2,000 r.p.m. for 10
minutes, decanting the supernatant, and resuspension of the sperm
in saline. After adding antibiotics (e.g., penicillin,
streptomyocin, etc.) in appropriate amount, the thrice washed sperm
is injected subcutaneously or intra-abdominally into rabbits in
successive injections, each injection involving the introduction of
approximately 18 to 20 million X-sperms. Following a procedure
customarily used to achieve hyper-immunization, the rabbits are
injected two times a week over a 6 week interval to thereby achieve
a total injection level of approximately 200,000,000 X-sperms. It
should be noted that before initiation of each of the foregoing
injection series, the experimental rabbit was tested for eventual
spontaneous agglutination of bull sperms, and any rabbits showing
such agglutination were eliminated. At the end of the 6 week period
of injections, a blood sample was taken from each test rabbit by a
procedure involving opening of a suitable blood vessel (i.e., an
ear vein) from which the blood was caused to flow into a container.
Blood specimens typically averaged 4 to 5 cc. Blood serum was
prepared in conventional manner by letting the blood stand for a
sufficient period of time (e.g., overnight) to achieve coagulation.
Clear non-coaguable blood serum (e.g., approximately 3 cc.) was
thereafter removed from the coagulum with a Pasteur pipette, and
placed in a small test tube or other suitable container.
The blood serum obtained by the foregoing procedure was tested for
its capacity to act as an agglutinin or precipitin with respect to
both X and Y-sperms, using the test method as generally described
by S. Kibrick, et al. in Volume 3 of the Journal of Reproductive
Fertility, 1962. In accordance with this procedure, the blood serum
is diluted with saline (0.9 percent NaCl in distilled H.sub.2 O) to
achieve dilutions of 1:10, 1:100 and 1:200. Two sets of dilutions
were prepared each containing about 0.2 ml. of diluted anti-serum.
To one set of the dilutions substantially pure fractions of X-sperm
in saline (i.e., approximately 10,000 sperm in a total volume of
0.2 ml.) were added. The approximately equal volumes of sperm
suspensions and anti-serums were mixed by sucking into a Pasteur
pipette and releasing to ensure thorough intermixing. To the other
set of dilutions was added a substantially pure Y-sperm fraction
(i.e., approximately 10,000 sperm in saline suspension to a total
volume of 0.2 ml.) using an identical procedure. The two sets of
dilutions containing alternatively X and Y-sperm were then placed
in an incubator at 37.degree. C. for 20 minutes. Following this
period of incubation, the two sets of dilutions were checked for
agglutination.
The following table shows the degree of agglutination separately
caused by adding X-sperm or Y-sperm to the different dilutions of
anti-X-sperm in saline.
Saline Degree of Agglutination Dilution X-sperm Y-sperm
__________________________________________________________________________
1:10 Marked None 1.phi. Moderate None 1:200 Slight None
__________________________________________________________________________
The foregoing table shows that the blood serum obtained from
rabbits injected with X-sperm contained antibodies against X-sperm
but no antibodies against Y-sperm.
From the foregoing it will be apparent that the immunological
method of the present invention has utility wherever it is desired
to control the sex of mammalian offspring. It is of extreme
practical and commercial importance in the field of animal
husbandry, for example, in permitting the breeder or farmer to have
a choice in selecting the sex of animal offspring. By way of
illustration, the dairy framer can elect to obtain only female
offspring and thereby advantageously breed only milk producing cows
rather than bulls. As respects human procreation, it provides
parents with a simple, easily employed means to select or control
the sex of offspring to quickly satisfy the desire to have a child
of a particular sex, thus providing the opportunity to reduce the
total number of children desired.
* * * * *